Ryder System (R) Tops Q1 EPS by 4c, Beats on Revenues; Boosts FY18 EPS Guidance
Get Alerts R Hot Sheet
Price: $262.96 +1.69%
Financial Fact:
Cash dividends declared and paid per common share: 0.44
Today's EPS Names:
MTEX, NSYS, PLNH, More
Financial Fact:
Cash dividends declared and paid per common share: 0.44
Today's EPS Names:
MTEX, NSYS, PLNH, More
Join SI Premium – FREE
Ryder System (NYSE: R) reported Q1 EPS of $0.91, $0.04 better than the analyst estimate of $0.87. Revenue for the quarter came in at $1.9 billion versus the consensus estimate of $1.89 billion.
- Q1 GAAP EPS from Continuing Operations Down $0.08 or 11% to $0.64, Includes $0.29 UK Goodwill Impairment Charge
- Q1 Comparable EPS (non-GAAP) from Continuing Operations Up $0.08 or 10% to $0.91, Reflects Lower Tax Rate from Tax Reform
- Record Q1 Total Revenue Grows 10% to $1.9 Billion; Record Q1 Operating Revenue (non-GAAP) Up 7% to $1.5 Billion
- Revised Full-Year 2018 GAAP EPS Forecast Range of $4.55 to $4.80 vs. Prior Forecast of $5.34 to $5.64, Driven by a Tax Reform-Related Adjustment and UK Goodwill Impairment Charge
- Revised Full-Year 2018 Comparable EPS Forecast Range (non-GAAP) of $5.45 to $5.70 vs. Prior Forecast of $5.40 to $5.70
GUIDANCE:
Ryder System sees FY2018 EPS of $5.45-$5.70, versus the consensus of $5.53.
For earnings history and earnings-related data on Ryder System (R) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Marchex (MCHX) Reports In-Line Q2 EPS
- ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share